scispace - formally typeset
T

Thomas Horn

Researcher at Chiron Corporation

Publications -  37
Citations -  1427

Thomas Horn is an academic researcher from Chiron Corporation. The author has contributed to research in topics: Oligonucleotide & Polynucleotide. The author has an hindex of 12, co-authored 37 publications receiving 1427 citations. Previous affiliations of Thomas Horn include Siemens & Bayer Corporation.

Papers
More filters
Patent

Polynucleotide reagents containing modified deoxyribose moieties and associated methods of synthesis and use

TL;DR: In this article, methods and reagents for synthesizing polynucleotides containing modified deoxyribose residues were provided for hybridization assay formats, which are useful in a variety of hybridization formats.
Patent

Multifunctional nucleic acid monomer

TL;DR: This paper introduced cleavable sites and/or abasic sites into oligonucleotide or polynucleotide chains, which are useful in a variety of biochemical and chemical contexts including nucleic hybridization assays and chemical phosphorylation of hydroxyl-containing compounds.
Patent

Nucleic acid hybridization assays employing large comb-type branched polynucleotides

TL;DR: Comb-type branched polynucleotides are used as amplification multimers in nucleic acid hybridization assays as discussed by the authors, where the polynomial is used as an amplification multimer.
Patent

Solution phase nucleic acid sandwich assay and polynucleotide probes useful therein

TL;DR: In this paper, two reagent sets are used to detect nucleic acid sequences. The first set is a labeling set consisting of an analyte complementary region and a first recognition sequence region, and the second set is capturing set comprising a second nucleic amino acid sequence probe and a specific binding pair member conjugated to a sequence complementary to the second recognition sequence.
Patent

Modified N-4 nucleotides for use in amplified nucleic acid hybridization assays

TL;DR: Linear or branched oligonucleotide multimers are useful as amplifiers in biochemical assays which comprise (1) at least one first single-stranded oligonotide unit that is complementary to a singlestranded sequence of interest, and (2) a multiplicity of second single strand-linked oligon nucleotide units that are complementary to the label of interest as discussed by the authors.